Search scope:
排序: Display mode:
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Houli Zhao, Yiyun Wang, Elaine Tan Su Yin, Kui Zhao, Yongxian Hu, He Huang
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 711-725 doi: 10.1007/s11684-020-0808-3
Keywords: chimeric antigen receptor T (CAR-T) cell lymphoma cytokine release syndrome (CRS) immune effector cell-associated
Advances on immune-related adverse events associated with immune checkpoint inhibitors
Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang
Frontiers of Medicine 2021, Volume 15, Issue 1, Pages 33-42 doi: 10.1007/s11684-019-0735-3
Keywords: cancer immunotherapy immune checkpoint inhibitors immune-related adverse events review
Frontiers of Medicine Pages 878-888 doi: 10.1007/s11684-023-0993-y
Keywords: uveal melanoma liver-directed therapy immune checkpoint blockade SIRT anti-PD-1 anti-CTLA-4
Natural killer cells in liver diseases
Meijuan Zheng, Haoyu Sun, Zhigang Tian
Frontiers of Medicine 2018, Volume 12, Issue 3, Pages 269-279 doi: 10.1007/s11684-018-0621-4
Keywords: natural killer cell phenotype immune activation immune tolerance liver diseases
Frontiers of Medicine doi: 10.1007/s11684-023-1017-7
Keywords: single-cell RNA-seq glioma radial glia primitive oligodendrocyte precursor cell immune escape
Fengxia YIN,Hui LIU,Shorgan BOU,Guangpeng LI
Frontiers of Agricultural Science and Engineering 2014, Volume 1, Issue 2, Pages 104-113 doi: 10.15302/J-FASE-2014003
Keywords: nuclear reprogramming somatic cell transcription factors transcriptomics
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 18-42 doi: 10.1007/s11684-022-0976-4
Keywords: non-small cell lung cancer driver mutations treatment strategy resistant mechanism immune-checkpoint
Immunometabolism: a new dimension in immunotherapy resistance
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 585-616 doi: 10.1007/s11684-023-1012-z
Keywords: immune cell immunometabolism metabolic reprogramming immunotherapy resistance tumor microenvironment immune checkpoint inhibitor
Frontiers of Medicine 2022, Volume 16, Issue 4, Pages 596-609 doi: 10.1007/s11684-021-0868-z
Keywords: innate immune checkpoint Siglec10 kidney renal clear cell carcinoma
Mesenchymal stem cells and immune disorders: from basic science to clinical transition
Shihua Wang, Rongjia Zhu, Hongling Li, Jing Li, Qin Han, Robert Chunhua Zhao
Frontiers of Medicine 2019, Volume 13, Issue 2, Pages 138-151 doi: 10.1007/s11684-018-0627-y
Keywords: mesenchymal stem cell clinical transition immune disorders
Challenges of NK cell-based immunotherapy in the new era
Fang Fang, Weihua Xiao, Zhigang Tian
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 440-450 doi: tzg@ustc.edu.cn
Keywords: natural killer cells immunotherapy adoptive transfer genetic modification immune checkpoint inhibitor
Frontiers of Medicine 2021, Volume 15, Issue 5, Pages 679-692 doi: 10.1007/s11684-021-0866-1
Keywords: metabolic reprogramming potential of electron transfer cell proliferation aerobic glycolysis cancer
Immune Regulatory Cell Biology and Clinical Applications to Prevent or Treat Acute Graft-Versus-Host Review
Bruce R. Blazar
Engineering 2019, Volume 5, Issue 1, Pages 98-105 doi: 10.1016/j.eng.2018.11.016
Keywords: Graft-versus-host disease (GVHD) Immune regulatory cells Cell therapy
Xuying Pei, Xiangyu Zhao, Yu Wang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Yingjun Chang, Xiaojun Huang
Frontiers of Medicine 2018, Volume 12, Issue 2, Pages 153-163 doi: 10.1007/s11684-017-0548-1
To establish optimal reference values for recovered immune cell subsets, we prospectively investigatedpost-transplant immune reconstitution (IR) in 144 patients who received allogeneic stem cell transplantationwith an IR comparable to the reference values display superior survival, and the levels of recovery in immunesuggest that data from this recipient cohort should be used as reference values for post-transplant immunecell counts in patients receiving HSCT.
Keywords: immune reconstitution hematopoietic stem cell transplantation event-free patients reference range
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 699-713 doi: 10.1007/s11684-022-0972-8
Keywords: anti-CD19 chimeric antigen receptor T immunotherapy diffuse large B cell lymphoma tumor microenvironment tumor-associated macrophage metabolism
Title Author Date Type Operation
A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma
Houli Zhao, Yiyun Wang, Elaine Tan Su Yin, Kui Zhao, Yongxian Hu, He Huang
Journal Article
Advances on immune-related adverse events associated with immune checkpoint inhibitors
Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang
Journal Article
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint
Journal Article
Distinct immune escape and microenvironment between RG-like and pri-OPC-like glioma revealed by single-cell
Journal Article
Oocyte-associated transcription factors in reprogramming after somatic cell nuclear transfer: a review
Fengxia YIN,Hui LIU,Shorgan BOU,Guangpeng LI
Journal Article
Treatment of advanced non-small cell lung cancer with driver mutations: current applications and future
Journal Article
Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient
Journal Article
Mesenchymal stem cells and immune disorders: from basic science to clinical transition
Shihua Wang, Rongjia Zhu, Hongling Li, Jing Li, Qin Han, Robert Chunhua Zhao
Journal Article
Challenges of NK cell-based immunotherapy in the new era
Fang Fang, Weihua Xiao, Zhigang Tian
Journal Article
Potential of electron transfer and its application in dictating routes of biochemical processes associated
Journal Article
Immune Regulatory Cell Biology and Clinical Applications to Prevent or Treat Acute Graft-Versus-Host
Bruce R. Blazar
Journal Article
Comparison of reference values for immune recovery between event-free patients receiving haploidentical
Xuying Pei, Xiangyu Zhao, Yu Wang, Lanping Xu, Xiaohui Zhang, Kaiyan Liu, Yingjun Chang, Xiaojun Huang
Journal Article